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Abstract (1) Removal of a carboxyi at residue 132 of subunit I 
of Rhodobacter sphaeroides cytochrome c oxidase significantly 
inhibits electron transfer and makes proton pumping undetect- 
able ]Fetter et al. (1995) Proc. Natl. Acad. Sci. USA 92, 1604- 
1608]. When reconstituted into phosphnlipid vesicles (COV), 
wild-type oxidase shows respiratory control that is partially 
released by either valinomycin or nigericin and fully released by 
the two ionophores combined. Under the same conditions, the 
D132A mutant COV show anomalous ionophore responses, 
including inhibition by valinomycin or by CCCP. Nevertheless, 
oxidase activity results in development of a similar membrane 
potential in COV containing either wild-type or DI32A oxidase, 
and the ionophore responses of the membrane potential are 
similar for both enzymes. (2) Long chain fatty acids such as 
arachidonic acid, but not fatty alcohols, stimulate steady-state 
electron transfer activity 3-7-fold, with either detergent-solubil- 
ized (purified) D132A oxidase or the reconstituted form. The 
effect is specific for this mutant and is not seen with wild-type or 
other mutants of similar overall activity. Arachidonate-treated 
D132A COV show normal ionophore responses to valinomycin 
and nigericin and full release of respiration in presence of both 
ionophores or of CCCP. Thus, arachidonate and some other 
fatty acids abolish the ionophore anomalies een when the D132A 
enzyme is reconstituted in their absence. (3) Fatty acid addition 
does not restore proton pumping, likely because fatty acids also 
induce proton permeability and some degree of uncoupling. A 
model of D132A function is presented and possible roles for the 
fatty acids in 'chemical rescue' of the mutant are discussed. 
either an alanine (DI32A) or an asparagine (D132N) strongly 
diminishes oxygen reduction activity and abolishes proton 
pumping. D132 is a substantial distance from the oxygen-re- 
active site and mutation of the residue does not perturb the 
spectral properties of the metal centers [4]. Similar effects are 
seen when the corresponding residue in Escherichia coli cyto- 
chrome bo3 is mutated [5,6]). 
Another effect of the D132N/A mutations is that the recon- 
stituted enzymes show anomalous responses to uncouplers 
and ionophores [4]. Valinomycin and CCCP, both singly 
and in combination, inhibit instead of stimulating turnover 
in reconstituted enzyme. The ionophores do not inhibit the 
purified enzyme directly and the oxygen reduction activity 
shows a similar decrease with increasing pH as wild-type, 
indicating that the inhibition is likely caused by changes in 
membrane potential (A~) and/or pH gradient (ApH) [4]. An 
understanding of these responses might clarify the pumping 
process itself. The present paper will show that (i) a normal 
membrane potential is formed by COV containing mutant 
enzyme and (ii) the defect of the D132A/N mutations can 
partially be overcome by addition of free fatty acids. The fatty 
acids also rectify the anomolous responses to uncouplers and 
ionophores, but repair of proton pumping has not been dem- 
onstrated. 
2. Materials and methods 
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I. Introduction 
The structures of cytochrome c oxidases both from a eu- 
karyote, beef heart [1,2], and from a prokaryote, Paracoccus 
[3], have been determined to 2.8 A resolution by X-ray crystal 
analysis. In addition to defining the positions of the electron 
acceptors and donors, the resulting structures how possible 
channels for the movement of both scalar protons to the oxy- 
gen-reactive binuclear center and pumped protons across the 
membrane [3]. At the entry of the proposed 'pumped proton' 
channel there is an evolutionarily conserved aspartate residue, 
numbered as D132 in Rhodobacter sphaeroides, mutation of 
which to remove the carboxyl moiety by substitution with 
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2.1. Methods 
COV were reconstituted using wild-type and D132A-mutated Rho- 
dobacter sphaeroides cytochrome c oxidases as described previously 
[4,7]. Mutant enzymes were also obtained as described previously [4] 
and both mutant and wild-type nzymes were isolated by the methods 
of Hosler et al. [7]. 
Spectrophotometry was performed using either a Perkin-Elmer 
Lambda 6 or a Beckman DU-7HS spectrophotometer. Membrane 
potentials were determined using the carbocyanine dye method. 
Fluorescence intensity was measured using a Perkin Elmer LS-50 
fluorescence spectrophotometer with an excitation wavelength of 622 
nm, and emission wavelength of 688 nm (10 nm slits), using 0.45 gM 
diSC(3)-5 as the membrane potential probe, a technique described 
previously for reconstituted beef heart enzyme [8]. Reconstituted ves- 
icles~ containing either wild-type enzyme or D132A mutant~ were 
added to 3 ml 10 mM K + HEPES buffer, pH 7.4, with 20 mM K2SO4 
and 50 mM sucrose at 30°C. Cytochrome c was added at a concen- 
tration of 1.1 ~M. As detailed in the legend to Fig. 1, nigericin was 
used to abolish ApH and valinomycin to release the membrane po- 
tential, returning fluorescence to its control level. 
Activities and respiratory controls were measured polarographically 
with appropriate closed thermostatted chambers containing Clark- 
type oxygen electrodes. Steady-state turnover was measured with 
horse heart cytochrome c, ascorbate and TMPD as substrates as de- 
scribed by Hosler et al. [7]. Proton pumping in wild-type, mutant, and 
beef heart-containing COV was estimated according to the method of 
Fetter et al. [4]. 
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2.2. Materials 
Fatty acids, fatty alcohols and arachidonate analogues were pur- 
chased from Sigma Chemical Co. Arachidonic acid was also pur- 
chased from Cayman Chemical. Samples from the two companies 
gave similar results. All were made up as 250 mM stock solutions 
in ethanol and stored at -20°C. Horse heart cytochrome c, purified 
as in [9], valinomycin, igericin and CCCP were from Sigma. Asolec- 
tin used in vesicle reconstitution (as 'type V! phosphatidylcholine') 
was also a Sigma product. 
3. Results 
3.1. Turnover and respiratory control in COV reconstituted 
with the D132A mutant, wild-type, and beef heart oxidases 
As described previously [4], the DI32A mutant enzyme re- 
constituted into COV has a relatively low turnover that is 
slowed even more by valinomycin or by CCCP. Subsequent 
complete abolition of pH gradients by nigericin fails to restore 
the original low level of  activity (see Fig. 3). This suggested 
the possibility that abnormal membrane potentials might be 
generated by the mutant enzyme, and experiments were car- 
ried out to examine membrane potential generation by the 
mutant enzyme. 
3.2. Determination of membrane potentials in reconstituted 
D132A and reconstituted wild-type CO V 
As shown in Fig. 1, the time courses and extent of mem- 
brane potential-dependent quenching of diSC(3)-5 fluorescence 
are similar for reconstituted COV containing wild-type en- 
zyme as for those containing the D132A mutant. Beef heart 
cytochrome c oxidase also gave similar responses (not shown). 
Addition of oxidized cytochrome c decreases measured fluor- 
escence by optical quenching. Ascorbate and TMPD addition 
initiates steady-state turnover and a build-up of membrane 
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Fig. l. Reconstituted Asp~a2Ala mutant enzyme shows a normal 
membrane potential. 1.1 gM oxidized cytochrome c was added as 
the substrate, causing an initial decrease in fluorescence unrelated to 
turnover. To generate steady-state urnover, 2.8 mM ascorbate and 
1.1 mM TMPD were added. This leads to a decrease in the fluores- 
cence of the probe, indicating the formation of a membrane poten- 
tial. Nigericin was added to 0.5 gM to release the pH gradient. Val- 
inomycin was then added to 0.67 gM which releases the membrane 
potential and causes an increase in fluorescence. 
potential (decreased fluorescence). Nigericin abolishes ApH, 
with a concomitant small further increase in membrane po- 
tential. Valinomycin, which inhibits D132A activity, abolishes 
the membrane potential and the fluorescence returns to the 
value seen before addition of reductant. Thus a membrane 
Table 1 
Fatty acid stimulation of D132A mutant activity increases with longer alkyl chains, while fatty alcohols have no effect 
Fatty acid or fatty alcohol added % activity 
Acid or alcohol concentration 
5 ~tM 50 gM 250 ~tM 
To DI32A mutant oxidase 
Acetate 90 80 70 
Propionate 80 70 70 
Propanol 90 90 90 
Octanoate 90 100 120 
Octanol 100 80 80 
Laurate 120 120 150 
Lauryl alcohol 110 100 70 
Palmitate 140 210 150 
Hexadecanol 120 90 80 
Oleate (18:1 zxg) 120 160 140 
Linoleate (18:2 A9'12) 190 260 310 
Linolenate (18 : 3 ~9,12,15) 130 170 150 
Arachidonate (20 :A5,8,11,14) 180 300 410 
Arachidonoyl alcohol 100 90 100 
Docosahexanoate (22:,64,7,10,13,16,19) 260 380 330 
Docosahexanol 90 90 130 
To wild-type oxidase 
Arachidonate 100 90 60 
Palmitate 110 110 100 
Hexadecanol 100 100 100 
Oleate 100 100 70 
Activity assayed polarographically as described in Section 2 with 13 nM Aspla2Ala mutant or wild-type nzyme in a medium containing 30 gM 
cytochrome c, 1.1 mM TMPD, and 2.8 mM ascorbate in 50 mM potassium phosphate, pH 6.5 at 25°C. All fatty acids or alcohols were dissolved in 
ethanol. Consecutive additions were made to a final concentration f 5, 50, and 250 gM to the enzyme during turnover. The numbers in the table 
are in percentages where 100% represents a turnover of 1200 s -~ for the wild-type nzyme and 50 s 1 for the mutant enzyme. 
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potential equivalent to that produced by wild-type and beef 
heart enzyme is also produced by the reconstituted D132A 
mutant enzyme. The anomalous ionophore responses there- 
fore do not reflect anomalies of membrane potential forma- 
tion by the mutant enzyme. 
3.3. Stimulation of Asp 132 mutants by free fatty acids" 
Fig. 2 shows the polarographically measured activities of 
purified, detergent-solubilized DI32A mutant enzyme with cy- 
tochrome c and ascorbate plus TMPD, and the effects of fatty 
acid addition to such systems. Arachidonic acid stimulated the 
activity of the mutant enzyme significantly, but not that of 
wild-type. With increasing fatty acid concentration, a maximal 
turnover of nearly 200 s 1 was attained, which compares with 
1200 s 1 obtained for wild-type enzyme under these condi- 
tions in the presence or absence of fatty acids. The induced 
cytochrome c oxidase activity is blocked by cyanide (trace A) 
or by azide (trace B) indicating that the fatty acid is affecting 
the oxidase and not inducing a secondary reaction. Controls 
without oxidase showed no significant changes in the back- 
ground rate of autoxidation induced by fatty acids. Another 
oxidase mutant at the same position, D132N, showed a simi- 
lar stimulation by fatty acids (not shown). 
Is the fatty acid carboxyl group or the hydrophobic tail 
more important for stimulation? Table 1 lists results that 
show that no stimulation occurred with propionate or acetate, 
indicating that more than an acidic group was required. Med- 
ium chain fatty acids (octanoic and lauric) showed some stim- 
ulation, but long chain unsaturated fatty acids (C16-22) had 
the greatest effects, while alcohols of all sizes were ineffective. 
Stimulation requires both a sizeable hydrophobic tail and an 
acidic head group. Flurbiprofin and indomethacin, analogues 
of arachidonic acid, stimulated Asp132Ala activity 40 and 
100%, respectively, emphazing the requirement of a large hy- 
drophobic group and a carboxyl moiety (data not shown). 
Similar experiments with arachidonate were performed with 
various wild-type, beef heart, and mutant oxidases (Table 2). 
Detergent-solubilized oxidases are commonly stimulated by 
phospholipid mixtures and the effects of 'asolectin' phospho- 
lipids were therefore also tested. No significant stimulation by 
arachidonate occurs with wild-type (cf. Table 1), beef heart or 
most mutant enzymes. T359A was slightly stimulated but a 
similar effect was seen with the alcohol. F391Q showed only 
activation by the fatty alcohol and asolectin, while M262L 
showed slight stimulation by both fatty acid and alcohol, 
but no mutant showed the stimulation seen with D132N. 
There was no correlation between phospholipid and fatty 
arachidonic acid 
B. 30 180 cyanide 
arachidonic \ 170 
60 nrnol azide 
v I 
2 mln 
Fig. 2. Arachidonic acid stimulation of the Asp132Ala mutant en- 
zyme. Enzyme activity was assayed as indicated in Section 2 and 
Table 1. (A) Stimulation of enzyme activity by multiple additions of 
arachidonic acid and inhibition by 2 mM cyanide. (B) Effect of 250 
gM arachidonic acid with subsequent inhibition by 9 mM azide. 
Numbers beside traces are activities in electronlaa3 per s. 
acid effects, indicating a unique fatty acid role in activating 
D132 mutants. 
3.4. Restoration by fatty acids of respiratory control in D132A 
COV, but no demonstrable restoration of proton pumping 
If fatty acids can partially restore enzyme turnover (Fig. 2) 
what are their effects upon the anomalous ionophore re- 
sponses of COV [4]? The behaviour of COV towards fatty 
acids either added to the enzyme being reconstituted or to 
the reaction mixture before addition of valinomycin and ni- 
gericin is shown in Fig. 3. The inhibitory effects of valinomy- 
cin and nigericin are prevented by fatty acid. Although this 
effect may be complicated by a dual fatty acid role of uncou- 
Table 2 
Stimulation of activity by arachidonic acid is unique to the D132A mutant enzyme 
Oxidase Initial activity % stimulation of activity with addition of 
(s -1) Arachidonic acid Arachidonyl alcohol Asolectin 
Wild-type 1400 0 0 20 
Beef heart 450 0 0 10 
AsplZ2Ala 50 300 0 0 
Thr35!~Ala 350 20 30 30 
Asp412Asn 370 0 0 40 
Phe am Gln 30 0 70 70 
Lys362Met 20 0 0 0 
Met 262 Leu(II) 130 40 20 0 
His25~Asn(lI) 10 0 0 0 
Mutant enzymes were tested by the protocol in Table 1 for stimulation by arachidonic acid or arachidonoyl a cohol. They were also tested with 
2 mg of asolectin phospholipid (cholate solubilized). Two mutations are in subunit II (ll, noted in parentheses), while the others are all in subunit I.
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Fig. 3. Effects of oleic acid upon respiratory control and activity of 
cytochrome c oxidase proteoliposomes. Polarographic experiments 
in sucrose-KCl-10 mM Hepes buffer pH 7.4, at 30°C, in 4 ml total 
volume. Additions of 6 mM Na ascorbate, 0.6 mM TMPD, 6 gM 
cytochrome c (horse heart) and 20 gl COV (approx. 3.5 nM cyto- 
chrome aa3 final) as indicated. Valinomycin (10 nM) and nigericin 
(1 gM) were subsequently added after (lower trace) or before (upper 
trace) addition of fatty acid. The lower trace shows the effect of 
adding 2.5 gM oleate to controlled state COV. Under these condi- 
tions a very small amount of added fatty acid was sufficient to in- 
duce increased turnover and conventional ionophore responses. The 
upper trace shows the effect of adding a higher amount of oleate 
(250 gM) to uncontrolled COV. Numbers on the traces indicate 
turnover in electrons/s per aa3. 
piing and stimulation, it is clear that the COV now behave 
more like those made with wild-type enzyme. 
Experiments were then carried out to determine whether 
proton pumping by mutant COV might also be restored by 
fatty acids. Arachidonate in the concentration range required 
for stimulation of vesicles, 50-250 gM, caused some loss of 
respiratory control in wild-type COV and lowering of H+/e -
ratios. Under these conditions, no restoration of proton 
pumping was detected with D132A COV. 
4. Discussion 
4.1. Effects of Ionophores and membrane potentials in D132A 
COV 
Why are D132N and D132A mutant COV inhibited by 
valinomycin and CCCP ('reverse respiratory control')? This 
inhibition occurs despite the abolition of membrane potential 
and ApH by the ionophores and, unlike the case with inhibi- 
tion by low levels of valinomycin [10], cannot be accounted 
for by an increase in ApH. In steady state, cytochrome oxi- 
dase takes up protons from the interior to generate membrane 
potential and ApH. Reconstituted D132A cytochrome c oxi- 
dase generates a normal membrane potential under steady- 
state conditions, indicating that the enzyme is inserted cor- 
rectly in the membrane and at least the scalar protons are 
taken up normally from the vesicle interior via a 'substrate 
proton' pathway. However, if turnover is limited by blockage 
of proton uptake via a separate 'pumping' pathway involving 
D132, it is possible that this block could be partially overcome 
through reversal of the normal exit route. The existence of a 
gradient would make it easier for protons to be pulled in from 
the outside of the vesicles (Fig. 4C), while removal of mem- 
brane potential would decrease the rate of H + uptake and 
slow enzyme turnover, as is observed (Fig. 4B). 
4.2. Fatty acid stimulation of activity and restoration of 
respiratory control 
Fatty acids restore significant electron transfer activity in 
the D132N/A mutant enzymes. No stimulation is observed for 
other mutants with equally low activity, or wild-type nzyme, 
although a small stimulation can sometimes be detected with 
normal or BSA-treated samples of beef heart enzyme [11-13]. 
The D132N/A mutants are not markedly stimulated by phos- 
pholipids; therefore fatty acid stimulation must be of a differ- 
ent nature. 
Mutation of D132 to remove the carboxyl moiety may cre- 
ate a defect hat can be remedied by insertion of the fatty acid 
in the enzyme so that its carboxyl is in an appropriate posi- 
tion to replace the missing functional group. A less likely 
alternative is that the mutation has induced loss of an intrinsic 
fatty acid that has a functional role (cf. [13]). If the fatty acid 
is complementing the loss of the D132 carboxyl, or interacting 
at another site to improve proton access, this resembles the 
chemical rescue phenomenon observe with carboxylate mu- 
tants of other proton transferring membrane proteins. In mu- 
tated bacteriorhodopsin [14,15] and bacterial photosynthetic 
reaction center [16] activity can be restored by weak acid 
anions such as azide. These water soluble acids are required 
at much higher concentrations (approaching molar), as op- 
posed to micromolar for the fatty acid effects. The most ef- 
fective of these soluble weak acids cannot be used with cyto- 
chrome oxidase because they are inhibitors. 
The model in Fig. 4A illustrates how protons could be 
taken up and released in the wild-type oxidase to accomplish 
oxygen reduction and proton pumping in a manner consistent 
with mutagenesis results and theoretical considerations sug- 
gesting separate pumping and substrate proton pathways 
[3,17]. The mutation of D132 is depicted in Fig. 4B in the 
absence of a membrane potential. Uptake of protons from 
the matrix through the normal proton channel is blocked, 
but some activity is permitted due to proton back leak 
through the exit path. Proton backleak would be required 
to provide protons at the active site for charge compensation 
to enable turnover. Establishing a membrane potential (Fig. 
4C) would increase the rate of influx of protons from outside 
the vesicles through the exit route, accounting for the higher 
activity of the mutant in the absence of valinomycin or un- 
coupler. In Fig. 4D, fatty acids act to repair the loss of a 
carboxyl in the pumping pathway, facilitating proton uptake 
through the correct route and instigating higher activity with 
normal respiratory control. If this is the case, restoration of 
proton pumping would also be expected, along with electron 
transfer activity and the ionophore response. The latter two 
effects are seen, but so far we have been unable to show 
restoration of pumping. This is technically difficult because 
of the uncoupling effect fatty acids. It is also possible that 
the lack of pumping is due to the carboxyl of the fatty acid 
having a different pK~ than the aspartate it is replacing, re- 
sulting in facilitation of both influx and efflux of protons in 
the normal influx route. 
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Fig. 4. Model of proton pathways in wild-type and D132 mutant cytochrome oxidases: effect of membrane potential and of fatty acid addition. 
(A) Wild-type with an aspartate residue at position 132. (B) D132A mutant with no membrane potential but some activity due to reversibility 
of the normal exit pathway. (C) D132A mutant with a negative internal membrane potential giving higher activity due to facillitation of the en- 
try of protons through the exit path (reverse respiratory control). (D) D132A mutant with fatty acid replacing the lost carboxyl at the proton 
entry site and facillitating proton entry through the normal uptake pathway (higher activity with normal respiratory control). 
An alternative model for the fatty acid effect is that the 
fatty acid binds in or near the proton exit channel and further 
facilitates reverse proton uptake, lessening the need for the 
membrane potential  but still producing an uncoupled activity. 
This second model does not explain the reestablishment of
respiratory control  or the lack of effect of fatty acids on 
wild-type or other mutants.  
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